Dolutegravir resistance has not risen in Lesotho cohort
European guidelines widen access to two-drug HIV treatment
A pair of antibodies keeps HIV undetectable by ‘bolting the door and masking the key’
“Normal is the perfect word”: participants describe switching to weekly HIV treatment
Moving to HIV self-care would be better and cheaper for Africa
Without US funding, Zimbabwe could see over 75,000 new HIV infections in a year
Modelling shows doxyPEP could account for 1.9% of doxycycline use in Europe
From “good news” to “failure”: how French participants experienced an HIV remission trial
In Asia, on-demand PrEP could be an “economically efficient” way to prevent HIV
